Harvard Bioscience Inc
Veridion Score
Composite trend over time
Why is HBIO moving today?
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for HBIO.
HBIO insider activity
Harvard Bioscience Inc
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for HBIO.
HBIO contract awards, year to date.
Public federal awards linked to this ticker.
HBIO lobbying filings, year to date.
Registered lobbying filings matched to Harvard Bioscience Inc.